Fish Oil, Insulin Sensitivity, Insulin Secretion and Glucose Tolerance in Healthy People: is There Any Effect of Fish Oil Supplementation in Relation to the Type of Background Diet and Habitual Dietary Intake of N-6 and N-3 Fatty Acids?
Overview
Authors
Affiliations
Aim: To evaluate whether a moderate supplementation of long-chain n-3 fatty acids is able to modulate insulin sensitivity, insulin secretion, beta-cell function and glucose tolerance in healthy individuals consuming a diet rich in either saturated or monounsaturated fat, also in relation to their habitual dietary intake of n-6 and n-3 fatty acid.
Methods And Results: One hundred and sixty-two healthy individuals were randomly assigned to follow either one of two isoenergetic diets for 3 months, one rich in monounsaturated fats and the other rich in saturated fats. Within each group there was a second randomisation to fish oil (n-3 fatty acids 3.6 g/day) or placebo. At the beginning and at the end of the treatment periods insulin sensitivity (SI), first phase insulin response (FPIR) and glucose tolerance (K(G)-value) were evaluated by the intravenous glucose tolerance test (IVGTT). Fish oil did not have any effect on SI, FPIR, K(G)-value and disposition index in either diet. Even after dividing subjects according to the median value of n-6/n-3 ratio of serum phospholipids at baseline, there was no change in SI (Delta SI 0.42+/-0.34 on fish oil vs 0.14+/-0.23 on placebo for those with n-6/n-3 <4.85; -1.03+/-0.47 on fish oil vs -0.27+/-0.32 on placebo for those with n-6/n-3 >4.85) (M+/-SE), FPIR (Delta FPIR 135.9+/-78.9 vs 157.2+/-157.5 pmol/L; 38.8+/-181.7 vs 357.1+/-181.7 pmol/L), K(G)-value (Delta K(G) 0.14+/-0.15 vs 0.12+/-0.11; -0.32+/-0.16 vs 0.15+/-0.15) or disposition index (Delta disposition index 1465.4+/-830.4 vs 953.8+/-690.0; -1641.6+/-1034.3 vs 446.6+/-905.1). Considering the 75th percentile of n-6/n-3 ratio (5.82) the results on insulin sensitivity, insulin secretion and disposition index were confirmed, while, in this more extreme situation, n-3 fatty acid supplementation induced a significant deterioration of K(G)-value (p=0.02).
Conclusions: In healthy individuals a moderate supplementation of fish oil does not affect insulin sensitivity, insulin secretion, beta-cell function or glucose tolerance. The same is true even when the habitual dietary intake of n-6 and n-3 fatty acids is taken into account.
Wang L, Wiedmann T, Kandimalla K Int J Pharm. 2022; 622:121823.
PMID: 35605891 PMC: 9881744. DOI: 10.1016/j.ijpharm.2022.121823.
Khalili L, Valdes-Ramos R, Harbige L Metabolites. 2021; 11(11).
PMID: 34822400 PMC: 8620218. DOI: 10.3390/metabo11110742.
Effect of omega-3 fatty acids on glucose homeostasis: role of free fatty acid receptor 1.
El-Fayoumi S, Mahmoud A, Fahmy A, Ibrahim I Naunyn Schmiedebergs Arch Pharmacol. 2020; 393(10):1797-1808.
PMID: 32388601 DOI: 10.1007/s00210-020-01883-5.
den Biggelaar L, Eussen S, Sep S, Mari A, Ferrannini E, Van Greevenbroek M Eur J Nutr. 2018; 58(2):597-608.
PMID: 29525890 PMC: 6437317. DOI: 10.1007/s00394-018-1644-y.
An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids.
Yanai H, Masui Y, Katsuyama H, Adachi H, Kawaguchi A, Hakoshima M J Clin Med Res. 2018; 10(4):281-289.
PMID: 29511415 PMC: 5827911. DOI: 10.14740/jocmr3362w.